First Pacific Financial Cuts Holdings in Danaher Corporation $DHR

First Pacific Financial decreased its holdings in Danaher Corporation (NYSE:DHR) by 7.7% in the 2nd quarter, HoldingsChannel reports. The fund owned 3,197 shares of the conglomerate’s stock after selling 266 shares during the quarter. First Pacific Financial’s holdings in Danaher were worth $631,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. GHP Investment Advisors Inc. increased its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC increased its stake in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in Danaher during the first quarter worth $31,000. Dunhill Financial LLC boosted its position in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after buying an additional 67 shares in the last quarter. Finally, Costello Asset Management INC acquired a new stake in Danaher in the 1st quarter valued at about $41,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 6.4%

Shares of Danaher stock opened at $198.05 on Wednesday. The company has a fifty day moving average price of $199.55 and a 200 day moving average price of $197.31. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.41. The stock has a market cap of $141.82 billion, a price-to-earnings ratio of 42.14, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm’s revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is currently 27.23%.

Insider Activity

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 11.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reduced their target price on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. Guggenheim reiterated a “buy” rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. Robert W. Baird upped their target price on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a report on Friday, July 18th. Finally, Barclays reaffirmed an “overweight” rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $245.91.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.